Concerning nocturnal hypoglycemia, it was available from 20 clinical trials, and the meta-analysis results favor insulin analogues (RR 0.66; 95% CI 0.57; 0.76; I2 97.1%), meaning that the risk of having a hypo episode was reduced (Fig 2D). The gene discussed is INS; the disease is Hypoglycemia.